查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862181

畜牧疫苗：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Livestock Animal Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球牲畜疫苗市场规模估计为 57.66 亿美元，预计到 2031 年将达到 85.96 亿美元，在预测期（2025-2031 年）内复合年增长率为 5.9%。

本报告对近期关税调整和国际战略反制措施，涉及畜牧疫苗的跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组，进行了全面评估。

畜禽疫苗是用来预防和控制牲畜及其他经济动物感染疾病的生物製药。它们透过诱导特异性免疫反应，降低疾病发生率和死亡率，从而保障畜产品安全和食品供应链的稳定性。该类疫苗包括灭活疫苗、减毒活病毒疫苗、重组疫苗和次单位疫苗疫苗，可有效预防多种病原体，包括病毒、细菌和寄生虫。畜禽疫苗产业是全球动物健康和生物安全体系的基础，广泛应用于牛、猪、羊和家禽养殖。随着疾病防治政策日益严格、畜牧业的化和规模化的加速发展以及生物技术的不断进步，畜禽疫苗已成为现代畜牧业和公共卫生体系的重要策略组成部分。 2024年，全球畜禽疫苗产量预计将达到约4,300亿剂，全球平均市场价格约为每公斤13.4美元。

全球畜牧疫苗市场的发展主要受畜牧业工业化生产和大规模农业加速发展的推动，疾病预防和动物健康管理已成为关键的竞争优势。疫苗技术的快速创新，尤其是在mRNA、重组蛋白和奈米颗粒递送平台方面的创新，使得疫苗研发更加精准、高效和可追溯。政府对农业和动物健康政策的投入，以及对食品安全和公共卫生日益增长的关注，进一步扩大了疫苗的普及应用。跨国动物健康巨头和区域领导者正在加大研发投入，以提供涵盖多种疾病和物种的多元化疫苗组合。市场正朝着优质化、专业化和全球化方向发展。儘管成长前景强劲，但该行业仍面临诸多挑战，包括高昂的研发成本、漫长的监管核准流程以及复杂的国际贸易政策。动物病原体的多样性和快速变异要求疫苗的研发和检验必须及时且科学严谨。低温运输基础设施和储存要求增加了营运成本，尤其是在新兴市场。同时，该产业也面临突发性区域疾病爆发、贸易壁垒和激烈的价格竞争等挑战，这些都威胁盈利。企业必须持续投资于创新、智慧财产权保护和供应链优化，以维持市场韧性和产品竞争力。畜牧疫苗的需求正从传统的疾病预防转向高价值的精准健康管理解决方案。农民和动物健康组织正在引入联合疫苗和客製化免疫方案，以提高生产力和动物福利。意识提升，正在推动源头的无病生产，并加速优质疫苗和创新免疫技术的应用。数位化农场管理和精密农业解决方案正在推动疫苗市场与智慧农业和物联网平台之间的深度合作。

畜牧疫苗的生产高度依赖高品质的种子菌株、细胞株、培养基和佐剂系统，所有这些都受到严格的监管标准和重大的技术障碍的限制。全球上游市场高度集中，关键组件由少数几家跨国供应商和专业生物技术公司控制。生物发酵、无血清培养和奈米技术的进步使得某些原料的在地采购成为可能，提高了疫苗生产商的灵活性。然而，动物性原料的可追溯性、品质一致性和国际认证仍然是该产业面临的主要挑战，因此供应链安全是策略规划的核心要素。

本报告旨在按地区/国家、类型和应用对全球畜牧疫苗市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（百万剂）和收入（百万美元）为单位，对畜牧疫苗市场规模、估值和预测进行了呈现，基准年为2024年，并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定畜牧疫苗业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco
  • CAHIC
  • Jinyu Bio-Technology
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • Kyoto Biken Laboratories
  • WINSUN
  • FATRO
  • CAVAC
  • MEVAC
  • Biovac
  • Cavet bio
  • Vaksindo
  • Bio-Labs

按类型分類的细分市场

  • 活病毒疫苗
  • 灭活疫苗
  • 其他疫苗

应用领域

  • 猪
  • 牛
  • 家禽
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Livestock Animal Vaccines was estimated to be worth US$ 5766 million in 2024 and is forecast to a readjusted size of US$ 8596 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Livestock Animal Vaccines cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Livestock animal vaccines are biological products designed to prevent and control infectious diseases in livestock and other economically important animals. By inducing specific immune responses, they help reduce disease incidence and mortality, ensuring the safety of livestock production and the stability of the food supply chain. This category includes inactivated, live-attenuated, recombinant, and subunit vaccines, offering protection against a wide range of pathogens, including viruses, bacteria, and parasites. The livestock animal vaccine industry serves as a cornerstone of the global animal health and biosecurity system, widely applied in cattle, swine, sheep, and poultry farming. With increasingly stringent disease prevention policies, accelerating livestock industrialization and scaling, and continuous advancements in biotechnology, livestock animal vaccines have become an indispensable strategic component of modern animal husbandry and public health systems.In 2024, global livestock animal vaccines production reached approximately 430 billion units , with an average global market price of around US$ 13.4 per k dose.

The global livestock animal vaccines market is driven by accelerating livestock industrialization and large-scale farming, making disease prevention and animal health management key competitive advantages. Rapid innovation in vaccine technology, particularly mRNA, recombinant protein, and nanoparticle delivery platforms, is enabling more precise, efficient, and traceable vaccine development. Governmental investment in agriculture and animal health policies, combined with heightened focus on food safety and public health, has further expanded vaccine adoption. Multinational animal health leaders and regional champions are intensifying R&D efforts, offering diversified vaccine portfolios covering multiple diseases and species, while the market evolves toward premiumization, specialization, and globalization.Despite its strong growth prospects, the industry faces multiple hurdles, including high R&D costs, lengthy regulatory approval processes, and complex global trade policies. The diversity and rapid mutation of animal pathogens demand timely and scientifically rigorous vaccine development and validation. Cold-chain infrastructure and storage requirements increase operational costs, particularly in emerging markets. Meanwhile, sudden regional disease outbreaks, trade barriers, and intense price competition challenge profitability. Companies must continuously invest in innovation, intellectual property protection, and supply chain optimization to maintain market resilience and product competitiveness.Demand for livestock animal vaccines is shifting from traditional disease prevention to high-value, precision health management solutions. Livestock producers and animal health organizations are adopting combination vaccines and customized immunization programs to enhance productivity and animal welfare. Rising consumer awareness of food safety and animal welfare is driving the industry toward disease-free production at the source, accelerating adoption of premium vaccines and innovative immunization technologies. Digital farm management and precision farming solutions are fostering deeper integration between the vaccine market and smart agriculture or IoT-enabled platforms.

Livestock animal vaccine production relies heavily on high-quality seed strains, cell lines, culture media, and adjuvant systems, all of which involve stringent regulatory standards and high technological barriers. The global upstream market is highly concentrated, with key components controlled by a small number of multinational suppliers and biotech specialists. Advances in biofermentation, serum-free culture, and nanotechnology have enabled localized sourcing of certain raw materials, offering more flexibility to vaccine manufacturers. However, traceability, quality consistency, and international certification of animal-derived raw materials remain top industry concerns, making supply chain security a core component of strategic planning.

This report aims to provide a comprehensive presentation of the global market for Livestock Animal Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Livestock Animal Vaccines by region & country, by Type, and by Application.

The Livestock Animal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Dose) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Animal Vaccines.

Market Segmentation

By Company

  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco
  • CAHIC
  • Jinyu Bio-Technology
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • Kyoto Biken Laboratories
  • WINSUN
  • FATRO
  • CAVAC
  • MEVAC
  • Biovac
  • Cavet bio
  • Vaksindo
  • Bio-Labs

Segment by Type

  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Other Vaccines

Segment by Application

  • Pig
  • Cattle
  • Poultry
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Livestock Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Livestock Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Livestock Animal Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Livestock Animal Vaccines Product Introduction
  • 1.2 Global Livestock Animal Vaccines Market Size Forecast
    • 1.2.1 Global Livestock Animal Vaccines Sales Value (2020-2031)
    • 1.2.2 Global Livestock Animal Vaccines Sales Volume (2020-2031)
    • 1.2.3 Global Livestock Animal Vaccines Sales Price (2020-2031)
  • 1.3 Livestock Animal Vaccines Market Trends & Drivers
    • 1.3.1 Livestock Animal Vaccines Industry Trends
    • 1.3.2 Livestock Animal Vaccines Market Drivers & Opportunity
    • 1.3.3 Livestock Animal Vaccines Market Challenges
    • 1.3.4 Livestock Animal Vaccines Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Livestock Animal Vaccines Players Revenue Ranking (2024)
  • 2.2 Global Livestock Animal Vaccines Revenue by Company (2020-2025)
  • 2.3 Global Livestock Animal Vaccines Players Sales Volume Ranking (2024)
  • 2.4 Global Livestock Animal Vaccines Sales Volume by Company Players (2020-2025)
  • 2.5 Global Livestock Animal Vaccines Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Livestock Animal Vaccines Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Livestock Animal Vaccines Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Livestock Animal Vaccines
  • 2.9 Livestock Animal Vaccines Market Competitive Analysis
    • 2.9.1 Livestock Animal Vaccines Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Livestock Animal Vaccines Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Livestock Animal Vaccines as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Live Attenuated Vaccine
    • 3.1.2 Inactivated Vaccine
    • 3.1.3 Other Vaccines
  • 3.2 Global Livestock Animal Vaccines Sales Value by Type
    • 3.2.1 Global Livestock Animal Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Livestock Animal Vaccines Sales Value, by Type (2020-2031)
    • 3.2.3 Global Livestock Animal Vaccines Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Livestock Animal Vaccines Sales Volume by Type
    • 3.3.1 Global Livestock Animal Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Livestock Animal Vaccines Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Livestock Animal Vaccines Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Livestock Animal Vaccines Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pig
    • 4.1.2 Cattle
    • 4.1.3 Poultry
    • 4.1.4 Others
  • 4.2 Global Livestock Animal Vaccines Sales Value by Application
    • 4.2.1 Global Livestock Animal Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Livestock Animal Vaccines Sales Value, by Application (2020-2031)
    • 4.2.3 Global Livestock Animal Vaccines Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Livestock Animal Vaccines Sales Volume by Application
    • 4.3.1 Global Livestock Animal Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Livestock Animal Vaccines Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Livestock Animal Vaccines Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Livestock Animal Vaccines Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Livestock Animal Vaccines Sales Value by Region
    • 5.1.1 Global Livestock Animal Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Livestock Animal Vaccines Sales Value by Region (2020-2025)
    • 5.1.3 Global Livestock Animal Vaccines Sales Value by Region (2026-2031)
    • 5.1.4 Global Livestock Animal Vaccines Sales Value by Region (%), (2020-2031)
  • 5.2 Global Livestock Animal Vaccines Sales Volume by Region
    • 5.2.1 Global Livestock Animal Vaccines Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Livestock Animal Vaccines Sales Volume by Region (2020-2025)
    • 5.2.3 Global Livestock Animal Vaccines Sales Volume by Region (2026-2031)
    • 5.2.4 Global Livestock Animal Vaccines Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Livestock Animal Vaccines Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.4.2 North America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.5.2 Europe Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Livestock Animal Vaccines Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.7.2 South America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Livestock Animal Vaccines Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Livestock Animal Vaccines Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Livestock Animal Vaccines Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Livestock Animal Vaccines Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.3.2 United States Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.4.2 Europe Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.5.2 China Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.6.2 Japan Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.7.2 South Korea Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Livestock Animal Vaccines Sales Value, 2020-2031
    • 6.9.2 India Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Livestock Animal Vaccines Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Merck
    • 7.1.1 Merck Company Information
    • 7.1.2 Merck Introduction and Business Overview
    • 7.1.3 Merck Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Merck Livestock Animal Vaccines Product Offerings
    • 7.1.5 Merck Recent Development
  • 7.2 Boehringer Ingelheim
    • 7.2.1 Boehringer Ingelheim Company Information
    • 7.2.2 Boehringer Ingelheim Introduction and Business Overview
    • 7.2.3 Boehringer Ingelheim Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Boehringer Ingelheim Livestock Animal Vaccines Product Offerings
    • 7.2.5 Boehringer Ingelheim Recent Development
  • 7.3 Zoetis
    • 7.3.1 Zoetis Company Information
    • 7.3.2 Zoetis Introduction and Business Overview
    • 7.3.3 Zoetis Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Zoetis Livestock Animal Vaccines Product Offerings
    • 7.3.5 Zoetis Recent Development
  • 7.4 Ceva
    • 7.4.1 Ceva Company Information
    • 7.4.2 Ceva Introduction and Business Overview
    • 7.4.3 Ceva Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Ceva Livestock Animal Vaccines Product Offerings
    • 7.4.5 Ceva Recent Development
  • 7.5 Elanco
    • 7.5.1 Elanco Company Information
    • 7.5.2 Elanco Introduction and Business Overview
    • 7.5.3 Elanco Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Elanco Livestock Animal Vaccines Product Offerings
    • 7.5.5 Elanco Recent Development
  • 7.6 CAHIC
    • 7.6.1 CAHIC Company Information
    • 7.6.2 CAHIC Introduction and Business Overview
    • 7.6.3 CAHIC Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 CAHIC Livestock Animal Vaccines Product Offerings
    • 7.6.5 CAHIC Recent Development
  • 7.7 Jinyu Bio-Technology
    • 7.7.1 Jinyu Bio-Technology Company Information
    • 7.7.2 Jinyu Bio-Technology Introduction and Business Overview
    • 7.7.3 Jinyu Bio-Technology Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Jinyu Bio-Technology Livestock Animal Vaccines Product Offerings
    • 7.7.5 Jinyu Bio-Technology Recent Development
  • 7.8 HVRI
    • 7.8.1 HVRI Company Information
    • 7.8.2 HVRI Introduction and Business Overview
    • 7.8.3 HVRI Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 HVRI Livestock Animal Vaccines Product Offerings
    • 7.8.5 HVRI Recent Development
  • 7.9 Ringpu Biology
    • 7.9.1 Ringpu Biology Company Information
    • 7.9.2 Ringpu Biology Introduction and Business Overview
    • 7.9.3 Ringpu Biology Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Ringpu Biology Livestock Animal Vaccines Product Offerings
    • 7.9.5 Ringpu Biology Recent Development
  • 7.10 Yebio
    • 7.10.1 Yebio Company Information
    • 7.10.2 Yebio Introduction and Business Overview
    • 7.10.3 Yebio Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Yebio Livestock Animal Vaccines Product Offerings
    • 7.10.5 Yebio Recent Development
  • 7.11 DHN
    • 7.11.1 DHN Company Information
    • 7.11.2 DHN Introduction and Business Overview
    • 7.11.3 DHN Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 DHN Livestock Animal Vaccines Product Offerings
    • 7.11.5 DHN Recent Development
  • 7.12 Kyoto Biken Laboratories
    • 7.12.1 Kyoto Biken Laboratories Company Information
    • 7.12.2 Kyoto Biken Laboratories Introduction and Business Overview
    • 7.12.3 Kyoto Biken Laboratories Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Kyoto Biken Laboratories Livestock Animal Vaccines Product Offerings
    • 7.12.5 Kyoto Biken Laboratories Recent Development
  • 7.13 WINSUN
    • 7.13.1 WINSUN Company Information
    • 7.13.2 WINSUN Introduction and Business Overview
    • 7.13.3 WINSUN Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 WINSUN Livestock Animal Vaccines Product Offerings
    • 7.13.5 WINSUN Recent Development
  • 7.14 FATRO
    • 7.14.1 FATRO Company Information
    • 7.14.2 FATRO Introduction and Business Overview
    • 7.14.3 FATRO Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 FATRO Livestock Animal Vaccines Product Offerings
    • 7.14.5 FATRO Recent Development
  • 7.15 CAVAC
    • 7.15.1 CAVAC Company Information
    • 7.15.2 CAVAC Introduction and Business Overview
    • 7.15.3 CAVAC Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 CAVAC Livestock Animal Vaccines Product Offerings
    • 7.15.5 CAVAC Recent Development
  • 7.16 MEVAC
    • 7.16.1 MEVAC Company Information
    • 7.16.2 MEVAC Introduction and Business Overview
    • 7.16.3 MEVAC Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 MEVAC Livestock Animal Vaccines Product Offerings
    • 7.16.5 MEVAC Recent Development
  • 7.17 Biovac
    • 7.17.1 Biovac Company Information
    • 7.17.2 Biovac Introduction and Business Overview
    • 7.17.3 Biovac Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Biovac Livestock Animal Vaccines Product Offerings
    • 7.17.5 Biovac Recent Development
  • 7.18 Cavet bio
    • 7.18.1 Cavet bio Company Information
    • 7.18.2 Cavet bio Introduction and Business Overview
    • 7.18.3 Cavet bio Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Cavet bio Livestock Animal Vaccines Product Offerings
    • 7.18.5 Cavet bio Recent Development
  • 7.19 Vaksindo
    • 7.19.1 Vaksindo Company Information
    • 7.19.2 Vaksindo Introduction and Business Overview
    • 7.19.3 Vaksindo Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Vaksindo Livestock Animal Vaccines Product Offerings
    • 7.19.5 Vaksindo Recent Development
  • 7.20 Bio-Labs
    • 7.20.1 Bio-Labs Company Information
    • 7.20.2 Bio-Labs Introduction and Business Overview
    • 7.20.3 Bio-Labs Livestock Animal Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Bio-Labs Livestock Animal Vaccines Product Offerings
    • 7.20.5 Bio-Labs Recent Development

8 Industry Chain Analysis

  • 8.1 Livestock Animal Vaccines Industrial Chain
  • 8.2 Livestock Animal Vaccines Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Livestock Animal Vaccines Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Livestock Animal Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Livestock Animal Vaccines Market Trends
  • Table 2. Livestock Animal Vaccines Market Drivers & Opportunity
  • Table 3. Livestock Animal Vaccines Market Challenges
  • Table 4. Livestock Animal Vaccines Market Restraints
  • Table 5. Global Livestock Animal Vaccines Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Livestock Animal Vaccines Revenue Market Share by Company (2020-2025)
  • Table 7. Global Livestock Animal Vaccines Sales Volume by Company (2020-2025) & (M Dose)
  • Table 8. Global Livestock Animal Vaccines Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Livestock Animal Vaccines Price by Company (2020-2025) & (US$/Dose)
  • Table 10. Key Manufacturers Livestock Animal Vaccines Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Livestock Animal Vaccines Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Livestock Animal Vaccines
  • Table 13. Global Livestock Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Livestock Animal Vaccines as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Livestock Animal Vaccines Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Livestock Animal Vaccines Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Livestock Animal Vaccines Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Livestock Animal Vaccines Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Livestock Animal Vaccines Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Livestock Animal Vaccines Sales Volume by Type: 2020 VS 2024 VS 2031 (M Dose)
  • Table 22. Global Livestock Animal Vaccines Sales Volume by Type (2020-2025) & (M Dose)
  • Table 23. Global Livestock Animal Vaccines Sales Volume by Type (2026-2031) & (M Dose)
  • Table 24. Global Livestock Animal Vaccines Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Livestock Animal Vaccines Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Livestock Animal Vaccines Price by Type (2020-2025) & (US$/Dose)
  • Table 27. Global Livestock Animal Vaccines Price by Type (2026-2031) & (US$/Dose)
  • Table 28. Global Livestock Animal Vaccines Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Livestock Animal Vaccines Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Livestock Animal Vaccines Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Livestock Animal Vaccines Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Livestock Animal Vaccines Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Livestock Animal Vaccines Sales Volume by Application: 2020 VS 2024 VS 2031 (M Dose)
  • Table 34. Global Livestock Animal Vaccines Sales Volume by Application (2020-2025) & (M Dose)
  • Table 35. Global Livestock Animal Vaccines Sales Volume by Application (2026-2031) & (M Dose)
  • Table 36. Global Livestock Animal Vaccines Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Livestock Animal Vaccines Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Livestock Animal Vaccines Price by Application (2020-2025) & (US$/Dose)
  • Table 39. Global Livestock Animal Vaccines Price by Application (2026-2031) & (US$/Dose)
  • Table 40. Global Livestock Animal Vaccines Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Livestock Animal Vaccines Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Livestock Animal Vaccines Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Livestock Animal Vaccines Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Livestock Animal Vaccines Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Livestock Animal Vaccines Sales Volume by Region (M Dose): 2020 VS 2024 VS 2031
  • Table 46. Global Livestock Animal Vaccines Sales Volume by Region (2020-2025) & (M Dose)
  • Table 47. Global Livestock Animal Vaccines Sales Volume by Region (2026-2031) & (M Dose)
  • Table 48. Global Livestock Animal Vaccines Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Livestock Animal Vaccines Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Livestock Animal Vaccines Average Price by Region (2020-2025) & (US$/Dose)
  • Table 51. Global Livestock Animal Vaccines Average Price by Region (2026-2031) & (US$/Dose)
  • Table 52. Key Countries/Regions Livestock Animal Vaccines Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Livestock Animal Vaccines Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Livestock Animal Vaccines Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Livestock Animal Vaccines Sales Volume, (2020-2025) & (M Dose)
  • Table 56. Key Countries/Regions Livestock Animal Vaccines Sales Volume, (2026-2031) & (M Dose)
  • Table 57. Merck Company Information
  • Table 58. Merck Introduction and Business Overview
  • Table 59. Merck Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 60. Merck Livestock Animal Vaccines Product Offerings
  • Table 61. Merck Recent Development
  • Table 62. Boehringer Ingelheim Company Information
  • Table 63. Boehringer Ingelheim Introduction and Business Overview
  • Table 64. Boehringer Ingelheim Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 65. Boehringer Ingelheim Livestock Animal Vaccines Product Offerings
  • Table 66. Boehringer Ingelheim Recent Development
  • Table 67. Zoetis Company Information
  • Table 68. Zoetis Introduction and Business Overview
  • Table 69. Zoetis Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 70. Zoetis Livestock Animal Vaccines Product Offerings
  • Table 71. Zoetis Recent Development
  • Table 72. Ceva Company Information
  • Table 73. Ceva Introduction and Business Overview
  • Table 74. Ceva Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 75. Ceva Livestock Animal Vaccines Product Offerings
  • Table 76. Ceva Recent Development
  • Table 77. Elanco Company Information
  • Table 78. Elanco Introduction and Business Overview
  • Table 79. Elanco Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 80. Elanco Livestock Animal Vaccines Product Offerings
  • Table 81. Elanco Recent Development
  • Table 82. CAHIC Company Information
  • Table 83. CAHIC Introduction and Business Overview
  • Table 84. CAHIC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 85. CAHIC Livestock Animal Vaccines Product Offerings
  • Table 86. CAHIC Recent Development
  • Table 87. Jinyu Bio-Technology Company Information
  • Table 88. Jinyu Bio-Technology Introduction and Business Overview
  • Table 89. Jinyu Bio-Technology Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 90. Jinyu Bio-Technology Livestock Animal Vaccines Product Offerings
  • Table 91. Jinyu Bio-Technology Recent Development
  • Table 92. HVRI Company Information
  • Table 93. HVRI Introduction and Business Overview
  • Table 94. HVRI Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 95. HVRI Livestock Animal Vaccines Product Offerings
  • Table 96. HVRI Recent Development
  • Table 97. Ringpu Biology Company Information
  • Table 98. Ringpu Biology Introduction and Business Overview
  • Table 99. Ringpu Biology Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 100. Ringpu Biology Livestock Animal Vaccines Product Offerings
  • Table 101. Ringpu Biology Recent Development
  • Table 102. Yebio Company Information
  • Table 103. Yebio Introduction and Business Overview
  • Table 104. Yebio Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 105. Yebio Livestock Animal Vaccines Product Offerings
  • Table 106. Yebio Recent Development
  • Table 107. DHN Company Information
  • Table 108. DHN Introduction and Business Overview
  • Table 109. DHN Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 110. DHN Livestock Animal Vaccines Product Offerings
  • Table 111. DHN Recent Development
  • Table 112. Kyoto Biken Laboratories Company Information
  • Table 113. Kyoto Biken Laboratories Introduction and Business Overview
  • Table 114. Kyoto Biken Laboratories Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 115. Kyoto Biken Laboratories Livestock Animal Vaccines Product Offerings
  • Table 116. Kyoto Biken Laboratories Recent Development
  • Table 117. WINSUN Company Information
  • Table 118. WINSUN Introduction and Business Overview
  • Table 119. WINSUN Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 120. WINSUN Livestock Animal Vaccines Product Offerings
  • Table 121. WINSUN Recent Development
  • Table 122. FATRO Company Information
  • Table 123. FATRO Introduction and Business Overview
  • Table 124. FATRO Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 125. FATRO Livestock Animal Vaccines Product Offerings
  • Table 126. FATRO Recent Development
  • Table 127. CAVAC Company Information
  • Table 128. CAVAC Introduction and Business Overview
  • Table 129. CAVAC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 130. CAVAC Livestock Animal Vaccines Product Offerings
  • Table 131. CAVAC Recent Development
  • Table 132. MEVAC Company Information
  • Table 133. MEVAC Introduction and Business Overview
  • Table 134. MEVAC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 135. MEVAC Livestock Animal Vaccines Product Offerings
  • Table 136. MEVAC Recent Development
  • Table 137. Biovac Company Information
  • Table 138. Biovac Introduction and Business Overview
  • Table 139. Biovac Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 140. Biovac Livestock Animal Vaccines Product Offerings
  • Table 141. Biovac Recent Development
  • Table 142. Cavet bio Company Information
  • Table 143. Cavet bio Introduction and Business Overview
  • Table 144. Cavet bio Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 145. Cavet bio Livestock Animal Vaccines Product Offerings
  • Table 146. Cavet bio Recent Development
  • Table 147. Vaksindo Company Information
  • Table 148. Vaksindo Introduction and Business Overview
  • Table 149. Vaksindo Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 150. Vaksindo Livestock Animal Vaccines Product Offerings
  • Table 151. Vaksindo Recent Development
  • Table 152. Bio-Labs Company Information
  • Table 153. Bio-Labs Introduction and Business Overview
  • Table 154. Bio-Labs Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
  • Table 155. Bio-Labs Livestock Animal Vaccines Product Offerings
  • Table 156. Bio-Labs Recent Development
  • Table 157. Key Raw Materials Lists
  • Table 158. Raw Materials Key Suppliers Lists
  • Table 159. Livestock Animal Vaccines Downstream Customers
  • Table 160. Livestock Animal Vaccines Distributors List
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Livestock Animal Vaccines Product Picture
  • Figure 2. Global Livestock Animal Vaccines Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Livestock Animal Vaccines Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Livestock Animal Vaccines Sales Volume (2020-2031) & (M Dose)
  • Figure 5. Global Livestock Animal Vaccines Sales Price (2020-2031) & (US$/Dose)
  • Figure 6. Livestock Animal Vaccines Report Years Considered
  • Figure 7. Global Livestock Animal Vaccines Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Livestock Animal Vaccines Players Sales Volume Ranking (2024) & (M Dose)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Livestock Animal Vaccines Revenue in 2024
  • Figure 10. Livestock Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Live Attenuated Vaccine Picture
  • Figure 12. Inactivated Vaccine Picture
  • Figure 13. Other Vaccines Picture
  • Figure 14. Global Livestock Animal Vaccines Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Livestock Animal Vaccines Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Livestock Animal Vaccines Sales Volume by Type (2020 VS 2024 VS 2031) & (M Dose)
  • Figure 17. Global Livestock Animal Vaccines Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Livestock Animal Vaccines Price by Type (2020-2031) & (US$/Dose)
  • Figure 19. Product Picture of Pig
  • Figure 20. Product Picture of Cattle
  • Figure 21. Product Picture of Poultry
  • Figure 22. Product Picture of Others
  • Figure 23. Global Livestock Animal Vaccines Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 24. Global Livestock Animal Vaccines Sales Value Market Share by Application, 2024 & 2031
  • Figure 25. Global Livestock Animal Vaccines Sales Volume by Application (2020 VS 2024 VS 2031) & (M Dose)
  • Figure 26. Global Livestock Animal Vaccines Sales Volume Market Share by Application, 2024 & 2031
  • Figure 27. Global Livestock Animal Vaccines Price by Application (2020-2031) & (US$/Dose)
  • Figure 28. North America Livestock Animal Vaccines Sales Value (2020-2031) & (US$ Million)
  • Figure 29. North America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Europe Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Europe Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Asia Pacific Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Asia Pacific Livestock Animal Vaccines Sales Value by Region (%), 2024 VS 2031
  • Figure 34. South America Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. South America Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Middle East & Africa Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. Middle East & Africa Livestock Animal Vaccines Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Key Countries/Regions Livestock Animal Vaccines Sales Value (%), (2020-2031)
  • Figure 39. Key Countries/Regions Livestock Animal Vaccines Sales Volume (%), (2020-2031)
  • Figure 40. United States Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. United States Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 42. United States Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Europe Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Europe Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Europe Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 46. China Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. China Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 48. China Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Japan Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. Japan Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 51. Japan Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 52. South Korea Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. South Korea Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 54. South Korea Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 55. Southeast Asia Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. Southeast Asia Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 57. Southeast Asia Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 58. India Livestock Animal Vaccines Sales Value, (2020-2031) & (US$ Million)
  • Figure 59. India Livestock Animal Vaccines Sales Value by Type (%), 2024 VS 2031
  • Figure 60. India Livestock Animal Vaccines Sales Value by Application (%), 2024 VS 2031
  • Figure 61. Livestock Animal Vaccines Industrial Chain
  • Figure 62. Livestock Animal Vaccines Manufacturing Cost Structure
  • Figure 63. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed